Advances in Drug-induced Diseases Volume II

42k
Total downloads
197k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 30 Jun 2025

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

Xiang Li
Si-Qi Zhang
Ke-Rui Wang
Shi-Nan Wu
Meng-Yuan Wang
Cui-Ting Chen
Nuo Dong

doi 10.3389/fphar.2025.1498814

1,540 views

ORIGINAL RESEARCH

Published on 14 May 2025

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

Yuan-Yuan Wu
Qiong-Lian Huang
Zhan-Yang Luo
Xiao-Yun Song
You-Yang Shi
Jin-Zhou Zheng
Sheng Liu

doi 10.3389/fphar.2025.1529342

1,484 views

ORIGINAL RESEARCH

Published on 24 Apr 2025

Real-world pharmacovigilance analysis of drug-related cataracts using the FDA adverse event reporting system database

Xiang Li
Shu Wen Wang
Zhi-Jie Zhang
Zhan Yang Luo
Jia Feng Tang
Tao Tao

doi 10.3389/fphar.2025.1498191

1,826 views

CASE REPORT

Published on 22 Apr 2025

Potential synergistic effects of lenvatinib and aspirin in aortic dissection: a case report and literature review

Lan Luo
Hao Liang
Lin Yuan
Ya-Kun Wu

doi 10.3389/fonc.2025.1520770

1,376 views
1 citation

ORIGINAL RESEARCH

Published on 16 Apr 2025

A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database

Yunlin Yang
Jinfeng Liu
Wei Wei

doi 10.3389/fphar.2025.1510992

3,717 views

SYSTEMATIC REVIEW

Published on 19 Mar 2025

Immune checkpoint inhibitors-induced pancreatitis: a systematic review and real-world pharmacovigilance analysis

Wei Fang
Huanping Wang
Xiaoran Zhang
Hongxia Zhu
Wei Yan
Yang Gao

doi 10.3389/fphar.2025.1426847

2,297 views

ORIGINAL RESEARCH

Published on 10 Mar 2025

Signal detection and safety analysis of three tyrosine kinase inhibitors for HER-2 positive breast cancer: a retrospective study based on the FAERS database

Xiting Tang
Chengliang Wang
Yanwei Li
Jing Tang
Guoping Zhang
Li Chen

doi 10.3389/fphar.2025.1538881

1,726 views

ORIGINAL RESEARCH

Published on 18 Feb 2025

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database

Fang Wu
Siliang Wang
Xihui Xu
Weihui Zhang
Jie Zhou
Runyan Niu
Wenting Cai
Yonggong Yang
Mengying Liu
Jinping Zhang

doi 10.3389/fphar.2025.1459067

1,971 views
1 citation

ORIGINAL RESEARCH

Published on 13 Feb 2025

Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database

Peng Jia
Yusen Zhou
Yuan Gao
Shangyu Wang
Jiangliu Yin
Yixiang Lian
Quanyou Lai

doi 10.3389/fphar.2025.1524159

2,006 views

ORIGINAL RESEARCH

Published on 24 Jan 2025

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults

Hao Li
Manxue Jiang
Xiaona Pan
Lingti Kong

doi 10.3389/fphar.2025.1524702

1,736 views

ORIGINAL RESEARCH

Published on 10 Jan 2025

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

Jinming Cao
Zhicong Chen
Yan Wang
Yunpeng Ma
Zhen Yang
Jian Cai
Zhijun Xiao
Feng Xu

doi 10.3389/fphar.2024.1517546

2,390 views

ORIGINAL RESEARCH

Published on 06 Jan 2025

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

Xianyu Dai
Kai Yu
Yu Chang
Yuchuan Hou

doi 10.3389/fphar.2024.1466875

2,702 views
2 citations

Share on

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology
Pharmacology of Anti-Cancer Drugs
Pharmacoepidemiology
Pharmacology of Infectious Diseases

Participating Journals

Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- 3.3 impact factor
- 6.9 citescore

Impact

197kTopic views
135kArticle views
42kArticle downloads

View impact

Articles

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

Real-world pharmacovigilance analysis of drug-related cataracts using the FDA adverse event reporting system database

Potential synergistic effects of lenvatinib and aspirin in aortic dissection: a case report and literature review

A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database

Immune checkpoint inhibitors-induced pancreatitis: a systematic review and real-world pharmacovigilance analysis

Signal detection and safety analysis of three tyrosine kinase inhibitors for HER-2 positive breast cancer: a retrospective study based on the FAERS database

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database

Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology

Pharmacology of Anti-Cancer Drugs

Pharmacoepidemiology

Pharmacology of Infectious Diseases

Participating Journals

Frontiers in Oncology

Pharmacology of Anti-Cancer Drugs